ProShares Ultra Nasdaq Biotechnology (BIB) Chart & Stock Price History $41.61 +1.77 (+4.44%) As of 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock ProShares Ultra Nasdaq Biotechnology Stock Price Performance The ProShares Ultra Nasdaq Biotechnology (BIB) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has decreased 27.67%, with a year-to-date return of -17.86%. In the past month, the fund has decreased 1.42%, reflecting recent market activity. As of the latest close, ProShares Ultra Nasdaq Biotechnology traded at $39.84 with a market cap of $43.82 million and volume of 12,422 shares. Five years ago, the fund traded at $68.36, representing a 39.13% decrease over that period. At the time, it had a market cap of $180.95 million and a volume of 326,920 shares. Receive BIB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.00%1 Month Performance-1.42%3 Month Performance-24.58%Year-To-Date Performance-17.86%1 Year Performance-27.67%5 Year Performance-39.13% BIB Stock Chart for Thursday, May, 15, 2025 BIB Chart by TradingView ProShares Ultra Nasdaq Biotechnology Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2025$39.84$41.61+4.44%$41.61$39.7514,221 shs$45.77 million05/14/2025$41.48$39.84-3.95%$41.66$39.5612,422 shs$43.82 million05/13/2025$43.10$41.48-3.76%$42.01$41.0520,682 shs$45.63 million05/12/2025$39.63$43.10+8.76%$43.42$40.0935,619 shs$47.41 million05/09/2025$41.24$39.63-3.90%$42.23$39.6312,266 shs$43.59 million05/08/2025$41.53$41.24-0.70%$41.88$39.4716,324 shs$45.36 million05/07/2025$41.26$41.53+0.65%$41.75$40.818,594 shs$45.68 million05/06/2025$46.91$41.26-12.04%$45.63$41.2119,286 shs$45.39 million05/05/2025$47.58$46.91-1.41%$47.54$46.747,180 shs$51.60 million05/02/2025$46.31$47.58+2.74%$47.96$47.484,145 shs$52.34 million Get the Latest News and Ratings for BIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 05/01/2025$47.46$46.31-2.42%$47.14$46.223,910 shs$50.94 million04/30/2025$46.11$47.46+2.93%$47.46$45.708,343 shs$52.21 million04/29/2025$45.87$46.11+0.52%$46.39$44.434,533 shs$50.72 million04/28/2025$44.61$45.87+2.82%$46.16$44.8911,876 shs$50.46 million04/25/2025$46.00$44.61-3.02%$45.40$44.432,834 shs$49.07 million04/24/2025$44.35$46.00+3.72%$46.00$44.016,354 shs$51.06 million04/23/2025$43.05$44.35+3.02%$45.70$44.3018,972 shs$49.23 million04/22/2025$40.79$43.05+5.54%$43.05$41.277,196 shs$47.79 million04/21/2025$41.39$40.79-1.45%$42.00$40.605,922 shs$45.28 million04/18/2025$41.39$41.39$41.45$40.5814,031 shs$45.94 million04/17/2025$40.72$41.39+1.65%$41.45$40.5814,031 shs$45.94 million04/16/2025$42.21$40.72-3.53%$41.68$40.002,706 shs$45.20 million04/15/2025$42.55$42.21-0.80%$42.82$41.6614,068 shs$46.85 million04/14/2025$40.24$42.55+5.74%$42.85$40.7712,174 shs$47.23 million Related Companies F/m Emerald Life Sciences Innovation ETF Stock Price Chart Invesco Nasdaq Biotechnology ETF Stock Price Chart Global X HealthTech ETF Stock Price Chart Horizon Kinetics Medical ETF Stock Price Chart First Trust Nasdaq Pharmaceuticals ETF Stock Price Chart JPMorgan Healthcare Leaders ETF Stock Price Chart ProShares UltraShort Nasdaq Biotechnology Stock Price Chart Invesco Dorsey Wright Healthcare Momentum ETF Stock Price Chart Invesco S&P SmallCap Health Care ETF Stock Price Chart VanEck Biotech ETF Stock Price Chart Receive BIB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIB) was last updated on 5/15/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.